OPMD Data will be presented by Axovant to the European Society of Gene and Cell Therapy next week. Dr Fraser Wright is presenting. He worked on TT-033 as a consultant to Pfizer in the early days. It's interesting that the deal with Axovant was signed just one month after Dr Wright became their Chief Scientific Officer.
